Origo Biopharma raised 2.3 million euros from Sabadell Asabys and XesGalicia
07 July 2020
07 July 2020
Total investments received (USD): 2.59m
Round value (USD): 2.59m
Round investors:
Asabys Partners
Xesgalicia
Company: Origo Biopharma
Industry:
Health services
Pharma
Related deals
Ability Pharma closed a €2 million capital round through the crowdfunding platform Capital Cell.
Investments
17 November 2020
Pulmobiotics announced raising €2,000,000 of seed financing from Barcelona-based Invivo Ventures
Investments
14 April 2020
Belgium
Netherlands
Austria
Germany
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
France
Ireland
Italy
Portugal
United Kingdom